| negative regulation of immune system process | GO:0002683 | 209 | 0.631 | |
| positive regulation of nuclear transcribed mrna poly a tail shortening | GO:0060213 | 4 | 0.412 | |
| rna catabolic process | GO:0006401 | 29 | 0.398 | |
| rna 3 end processing | GO:0031123 | 20 | 0.348 | |
| t cell activation | GO:0042110 | 289 | 0.300 | |
| mrna 3 end processing | GO:0031124 | 16 | 0.291 | |
| gene silencing | GO:0016458 | 38 | 0.240 | |
| mrna catabolic process | GO:0006402 | 22 | 0.234 | |
| mrna processing | GO:0006397 | 63 | 0.233 | |
| nuclear transcribed mrna catabolic process | GO:0000956 | 16 | 0.210 | |
| gene silencing by mirna | GO:0035195 | 10 | 0.209 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.189 | |
| t cell proliferation | GO:0042098 | 120 | 0.187 | |
| lung development | GO:0030324 | 164 | 0.175 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.172 | |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 12 | 0.170 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.168 | |
| positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900153 | 5 | 0.155 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.140 | |
| rna processing | GO:0006396 | 105 | 0.139 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.137 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.135 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.133 | |
| neural tube development | GO:0021915 | 160 | 0.131 | |
| regulation of mrna metabolic process | GO:1903311 | 43 | 0.130 | |
| mrna metabolic process | GO:0016071 | 84 | 0.128 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.126 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.121 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.115 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.111 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.109 | |
| septum transversum development | GO:0003343 | 2 | 0.104 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.099 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.098 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.097 | |
| regulation of nuclear transcribed mrna poly a tail shortening | GO:0060211 | 4 | 0.092 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.089 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.088 | |
| developmental maturation | GO:0021700 | 193 | 0.085 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.085 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.084 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.084 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.082 | |
| regulation of mrna catabolic process | GO:0061013 | 6 | 0.080 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.080 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.079 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.079 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.079 | |
| negative regulation of translation | GO:0017148 | 22 | 0.078 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.078 | |
| cell adhesion | GO:0007155 | 329 | 0.078 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.074 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.073 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.073 | Human |
| fat cell differentiation | GO:0045444 | 160 | 0.073 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.073 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.072 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.072 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.069 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.068 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.067 | |
| activation of immune response | GO:0002253 | 138 | 0.066 | |
| ossification | GO:0001503 | 216 | 0.066 | |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 7 | 0.066 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.065 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.064 | |
| t cell differentiation | GO:0030217 | 174 | 0.063 | |
| activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:0097296 | 2 | 0.063 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.062 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.061 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.061 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.060 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 38 | 0.060 | |
| skin development | GO:0043588 | 220 | 0.058 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.058 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.058 | |
| amine metabolic process | GO:0009308 | 45 | 0.057 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.055 | |
| response to acid chemical | GO:0001101 | 111 | 0.055 | |
| negative regulation of t cell proliferation | GO:0042130 | 38 | 0.054 | |
| fertilization | GO:0009566 | 127 | 0.052 | |
| positive regulation of toll like receptor 4 signaling pathway | GO:0034145 | 1 | 0.052 | |
| rna splicing via transesterification reactions with bulged adenosine as nucleophile | GO:0000377 | 43 | 0.052 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.052 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.052 | |
| axonogenesis | GO:0007409 | 274 | 0.050 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.050 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.050 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.050 | |
| spongiotrophoblast layer development | GO:0060712 | 15 | 0.050 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.049 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.049 | |
| spermatid differentiation | GO:0048515 | 115 | 0.049 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.049 | |
| spermatogenesis | GO:0007283 | 284 | 0.049 | Rat |
| respiratory tube development | GO:0030323 | 167 | 0.048 | |
| male gamete generation | GO:0048232 | 285 | 0.048 | Rat |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 2 | 0.048 | |
| epithelial cell development | GO:0002064 | 159 | 0.047 | |
| positive regulation of mrna metabolic process | GO:1903313 | 17 | 0.047 | |
| inflammatory response | GO:0006954 | 244 | 0.046 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.046 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.045 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.045 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.044 | |
| angiogenesis | GO:0001525 | 201 | 0.044 | Human |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.043 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.043 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.042 | |
| organelle fission | GO:0048285 | 170 | 0.042 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.042 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.041 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.041 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.041 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.040 | Human |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.040 | |
| embryonic placenta development | GO:0001892 | 98 | 0.039 | |
| placenta development | GO:0001890 | 140 | 0.039 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.039 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.039 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.038 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.038 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.038 | Human |
| protein ubiquitination | GO:0016567 | 171 | 0.038 | |
| definitive hemopoiesis | GO:0060216 | 20 | 0.037 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.037 | |
| negative regulation of growth | GO:0045926 | 99 | 0.037 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.037 | |
| response to oxidative stress | GO:0006979 | 123 | 0.036 | Rat |
| urogenital system development | GO:0001655 | 261 | 0.036 | |
| protein catabolic process | GO:0030163 | 221 | 0.036 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.036 | |
| regulation of defense response | GO:0031347 | 233 | 0.036 | |
| positive regulation of mrna catabolic process | GO:0061014 | 5 | 0.035 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.035 | |
| limb morphogenesis | GO:0035108 | 149 | 0.035 | |
| cytokine production | GO:0001816 | 319 | 0.035 | |
| positive regulation of protein ubiquitination | GO:0031398 | 27 | 0.034 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.034 | |
| camera type eye development | GO:0043010 | 266 | 0.033 | |
| respiratory system development | GO:0060541 | 190 | 0.033 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.033 | |
| negative regulation of b cell apoptotic process | GO:0002903 | 7 | 0.033 | |
| maintenance of location | GO:0051235 | 89 | 0.033 | |
| translation | GO:0006412 | 93 | 0.032 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.031 | |
| macromolecule methylation | GO:0043414 | 120 | 0.031 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.031 | |
| cation homeostasis | GO:0055080 | 212 | 0.031 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.031 | Human |
| negative regulation of secretion | GO:0051048 | 61 | 0.030 | |
| male sex differentiation | GO:0046661 | 109 | 0.030 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.030 | |
| negative regulation of stem cell differentiation | GO:2000737 | 14 | 0.030 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.030 | Rat |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.030 | |
| multicellular organism growth | GO:0035264 | 161 | 0.030 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.029 | |
| limb development | GO:0060173 | 166 | 0.029 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.029 | |
| digestive tract development | GO:0048565 | 190 | 0.029 | |
| regulation of translation | GO:0006417 | 71 | 0.029 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.029 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.028 | |
| spermatid development | GO:0007286 | 108 | 0.028 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.028 | Human |
| immune effector process | GO:0002252 | 321 | 0.028 | |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.028 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.028 | |
| regulation of cell migration | GO:0030334 | 219 | 0.028 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.027 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.027 | |
| renal system development | GO:0072001 | 225 | 0.027 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.027 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.027 | |
| innate immune response | GO:0045087 | 157 | 0.027 | |
| muscle tissue development | GO:0060537 | 308 | 0.027 | Human |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.027 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.027 | |
| cell division | GO:0051301 | 120 | 0.026 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.026 | |
| myotube cell development | GO:0014904 | 60 | 0.026 | Human |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.026 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.026 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.026 | |
| response to light stimulus | GO:0009416 | 135 | 0.026 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.026 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.026 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.025 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.025 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.025 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.025 | |
| gland development | GO:0048732 | 330 | 0.025 | |
| organelle fusion | GO:0048284 | 28 | 0.025 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.025 | |
| natural killer cell activation | GO:0030101 | 44 | 0.025 | |
| blood circulation | GO:0008015 | 195 | 0.025 | |
| vesicle organization | GO:0016050 | 60 | 0.025 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.025 | |
| membrane fusion | GO:0061025 | 38 | 0.025 | |
| positive regulation of protein modification by small protein conjugation or removal | GO:1903322 | 30 | 0.025 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.024 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.024 | |
| regulation of cell growth | GO:0001558 | 91 | 0.024 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.024 | |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.024 | |
| negative regulation of translation involved in gene silencing by mirna | GO:0035278 | 2 | 0.024 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.024 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.024 | |
| oocyte axis specification | GO:0007309 | 2 | 0.024 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.024 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.024 | |
| b cell activation | GO:0042113 | 161 | 0.024 | |
| positive regulation of mrna processing | GO:0050685 | 16 | 0.024 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.024 | |
| proepicardium development | GO:0003342 | 2 | 0.024 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.023 | |
| mesenchyme development | GO:0060485 | 152 | 0.023 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.023 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.023 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.023 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.023 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.023 | |
| membrane organization | GO:0061024 | 245 | 0.023 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.023 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.022 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.022 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.022 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.022 | |
| b cell proliferation | GO:0042100 | 53 | 0.022 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.022 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.022 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.021 | |
| cation transport | GO:0006812 | 399 | 0.021 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.021 | |
| cochlear nucleus development | GO:0021747 | 4 | 0.021 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.021 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.021 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.021 | |
| sensory system development | GO:0048880 | 3 | 0.021 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.021 | |
| regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0000083 | 3 | 0.021 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.021 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.021 | |
| b cell differentiation | GO:0030183 | 78 | 0.021 | |
| labyrinthine layer morphogenesis | GO:0060713 | 21 | 0.021 | |
| regulation of antigen receptor mediated signaling pathway | GO:0050854 | 29 | 0.021 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.021 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.021 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.021 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.021 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.020 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.020 | |
| retrograde transport endosome to golgi | GO:0042147 | 2 | 0.020 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.020 | |
| regulation of cell activation | GO:0050865 | 289 | 0.020 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.020 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.020 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.020 | |
| glial cell differentiation | GO:0010001 | 131 | 0.020 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.020 | |
| epithelial tube formation | GO:0072175 | 130 | 0.020 | |
| b cell apoptotic process | GO:0001783 | 19 | 0.020 | |
| appendage development | GO:0048736 | 166 | 0.020 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.020 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.020 | |
| rna interference | GO:0016246 | 2 | 0.020 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.020 | |
| signal transduction in absence of ligand | GO:0038034 | 55 | 0.020 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.019 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.019 | |
| midgut development | GO:0007494 | 4 | 0.019 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.019 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.019 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.019 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.019 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.019 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.019 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.019 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.019 | |
| rhythmic process | GO:0048511 | 174 | 0.019 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.019 | |
| primary neural tube formation | GO:0014020 | 95 | 0.019 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.019 | |
| skin morphogenesis | GO:0043589 | 38 | 0.019 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.019 | |
| methylation | GO:0032259 | 134 | 0.019 | |
| regulation of b cell apoptotic process | GO:0002902 | 13 | 0.019 | |
| nuclear division | GO:0000280 | 158 | 0.019 | |
| notch signaling pathway | GO:0007219 | 71 | 0.019 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.019 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.019 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.018 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.018 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.018 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.018 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.018 | Human |
| response to ischemia | GO:0002931 | 14 | 0.018 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.018 | Human |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.018 | Human |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.018 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.018 | |
| regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:1900151 | 5 | 0.018 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.018 | |
| tube closure | GO:0060606 | 91 | 0.018 | |
| chorio allantoic fusion | GO:0060710 | 8 | 0.018 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.018 | |
| lateral line system development | GO:0048925 | 1 | 0.018 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.018 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.018 | Human |
| organelle localization | GO:0051640 | 179 | 0.017 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.017 | |
| cellular response to starvation | GO:0009267 | 57 | 0.017 | |
| female gonad development | GO:0008585 | 71 | 0.017 | |
| cell maturation | GO:0048469 | 127 | 0.017 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.017 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.017 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.017 | |
| negative regulation of endopeptidase activity | GO:0010951 | 44 | 0.017 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.017 | |
| nephron development | GO:0072006 | 109 | 0.017 | |
| negative regulation of lymphocyte apoptotic process | GO:0070229 | 24 | 0.017 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.017 | |
| neural tube formation | GO:0001841 | 108 | 0.017 | |
| protein localization to organelle | GO:0033365 | 185 | 0.017 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.017 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.017 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.017 | |
| necrotic cell death | GO:0070265 | 30 | 0.017 | |
| mrna splicing via spliceosome | GO:0000398 | 43 | 0.017 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.017 | |
| oocyte construction | GO:0007308 | 2 | 0.017 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.017 | Mouse |
| positive regulation of intracellular steroid hormone receptor signaling pathway | GO:0033145 | 4 | 0.017 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.016 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.016 | |
| epidermis development | GO:0008544 | 187 | 0.016 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.016 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.016 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.016 | |
| t cell homeostatic proliferation | GO:0001777 | 4 | 0.016 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.016 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.016 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.016 | |
| positive regulation of lymphocyte apoptotic process | GO:0070230 | 13 | 0.016 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.016 | |
| response to oxygen levels | GO:0070482 | 62 | 0.016 | |
| cerebral cortex development | GO:0021987 | 86 | 0.016 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.016 | |
| neuronal action potential | GO:0019228 | 54 | 0.016 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.016 | Human |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.016 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.016 | |
| regulation of cell size | GO:0008361 | 72 | 0.016 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.016 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.016 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.016 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.016 | |
| regulation of ossification | GO:0030278 | 112 | 0.016 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.016 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 26 | 0.016 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.016 | |
| embryonic placenta morphogenesis | GO:0060669 | 25 | 0.016 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.016 | |
| glucose transport | GO:0015758 | 56 | 0.015 | |
| interleukin 8 production | GO:0032637 | 4 | 0.015 | |
| liver development | GO:0001889 | 66 | 0.015 | |
| inter male aggressive behavior | GO:0002121 | 3 | 0.015 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.015 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.015 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.015 | |
| dephosphorylation | GO:0016311 | 129 | 0.015 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 85 | 0.015 | |
| viral gene expression | GO:0019080 | 3 | 0.015 | |
| peptide secretion | GO:0002790 | 114 | 0.015 | |
| blood coagulation | GO:0007596 | 76 | 0.015 | |
| nephron epithelium development | GO:0072009 | 92 | 0.015 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.015 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.015 | |
| regulation of protein localization | GO:0032880 | 231 | 0.015 | |
| skeletal system development | GO:0001501 | 356 | 0.015 | |
| organ growth | GO:0035265 | 117 | 0.015 | |
| tube formation | GO:0035148 | 140 | 0.015 | |
| female gamete generation | GO:0007292 | 74 | 0.015 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.015 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.015 | |
| regulation of microvillus assembly | GO:0032534 | 3 | 0.015 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.015 | |
| pharynx development | GO:0060465 | 1 | 0.015 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.015 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.015 | |
| stem cell differentiation | GO:0048863 | 268 | 0.015 | |
| digestive system development | GO:0055123 | 200 | 0.015 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.015 | |
| hexose transport | GO:0008645 | 56 | 0.015 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.015 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.014 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.014 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.014 | |
| telencephalon development | GO:0021537 | 186 | 0.014 | |
| regulation of fibroblast proliferation | GO:0048145 | 34 | 0.014 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.014 | |
| protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | GO:0001844 | 4 | 0.014 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.014 | |
| neural tube closure | GO:0001843 | 90 | 0.014 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.014 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.014 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.014 | |
| mapk cascade | GO:0000165 | 281 | 0.014 | |
| action potential | GO:0001508 | 78 | 0.014 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.014 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.014 | |
| protein processing | GO:0016485 | 163 | 0.014 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.014 | Mouse |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.014 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.014 | Human |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.014 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.014 | |
| cell growth | GO:0016049 | 130 | 0.014 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.014 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.014 | Human |
| regulation of protein maturation | GO:1903317 | 96 | 0.014 | |
| muscle fiber development | GO:0048747 | 76 | 0.014 | Human |
| regulation of organelle organization | GO:0033043 | 289 | 0.014 | |
| pigmentation | GO:0043473 | 71 | 0.014 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.014 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.014 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.014 | |
| response to nutrient levels | GO:0031667 | 109 | 0.014 | |
| response to superoxide | GO:0000303 | 16 | 0.014 | |
| single organism nuclear import | GO:1902593 | 95 | 0.014 | |
| glomerulus development | GO:0032835 | 40 | 0.014 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.014 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.014 | |
| gonad development | GO:0008406 | 141 | 0.014 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.014 | |
| mesenchymal cell apoptotic process involved in metanephros development | GO:1900200 | 4 | 0.013 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.013 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.013 | |
| peptide transport | GO:0015833 | 133 | 0.013 | |
| blastocyst development | GO:0001824 | 80 | 0.013 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.013 | |
| protein maturation | GO:0051604 | 176 | 0.013 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.013 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.013 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.013 | |
| glycolipid metabolic process | GO:0006664 | 25 | 0.013 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.013 | |
| transmembrane transport | GO:0055085 | 412 | 0.013 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.013 | |
| negative regulation of retinal cell programmed cell death | GO:0046671 | 2 | 0.013 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.013 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.013 | |
| negative regulation of protein kinase activity by regulation of protein phosphorylation | GO:0044387 | 2 | 0.013 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.013 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.013 | |
| regulation of microvillus organization | GO:0032530 | 3 | 0.013 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.013 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.013 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.013 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.013 | |
| positive regulation of intracellular estrogen receptor signaling pathway | GO:0033148 | 4 | 0.013 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.013 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.013 | |
| lateral inhibition | GO:0046331 | 1 | 0.013 | |
| extracellular structure organization | GO:0043062 | 148 | 0.013 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.013 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 77 | 0.013 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.013 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.013 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.013 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.012 | |
| regulation of cell division | GO:0051302 | 76 | 0.012 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.012 | |
| forebrain development | GO:0030900 | 302 | 0.012 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001267 | 4 | 0.012 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.012 | |
| response to radiation | GO:0009314 | 165 | 0.012 | |
| response to peptide | GO:1901652 | 136 | 0.012 | Rat |
| peptidyl serine modification | GO:0018209 | 83 | 0.012 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.012 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.012 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.012 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.012 | |
| protein insertion into mitochondrial membrane | GO:0051204 | 4 | 0.012 | |
| mitochondrion organization | GO:0007005 | 134 | 0.012 | |
| metencephalon development | GO:0022037 | 89 | 0.012 | |
| regulation of chromatin silencing | GO:0031935 | 2 | 0.012 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.012 | |
| regulation of protein processing | GO:0070613 | 96 | 0.012 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.012 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.012 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.012 | |
| zymogen activation | GO:0031638 | 41 | 0.012 | |
| mammary gland involution | GO:0060056 | 9 | 0.012 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.012 | |
